HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Targets Spring 2019 For Cosmetics Manufacturing Survey; PCPC Input Taken

This article was originally published in The Rose Sheet

Executive Summary

From the Personal Care Products Council’s standpoint, FDA’s planned survey of current manufacturing practices in the cosmetics sector isn’t necessary, but the group provided input to contractor RTI to help develop the instrument for optimal utility. Pending OMB approval, FDA aims to launch the survey in spring 2019.

You may also be interested in...



MoCRA Confidentiality For AE Reports? And Other Questions Raised At IBA Regulatory Forum

Independent Beauty Association president and CEO Don Frey, Kerry Tassopoulos of Platt Cheema Richmond PLLC, and IBA board member and Co-CEO and president Craig Weiss of the Consumer Product Testing Company fielded questions on MoCRA implementation at IBA’s 2023 Technical/Regulatory Forum.

FDA’s Cosmetics Manufacturing Survey Under Way; J&J, Colgate Jointly Defending Talc In California; News In Brief

FDA moves ahead with its plan to survey the cosmetics industry on current manufacturing practices, with 900 companies selected for invitations to participate. More cosmetics news in brief.

116th Congress Could Test Cosmetic Industry’s Commitment To Reg Reform, Preemption Viability

With Democrats in control of the House and New Jersey Rep. Frank Pallone in line for chair of the Energy & Commerce Committee, cosmetics regulatory reform legislation could receive even more attention in the 116th Congress than in the current session. The new climate could test how serious big business is about embracing large-scale changes as well as lawmakers’ openness to federal preemption. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel